Patient Engagement for Medicines Development in a nutshell

Improve global health by co-designing the future of healthcare for patients with patients

What is needed for meaningful patient engagement in medicines development?

Globally accepted guiding principles around patient engagement and co-ordination of efforts

A platform for routinely sharing experience, leveraging and integrating good practices

An effective, measurable and reliable meta-framework that integrates the voice of the patient across the medicines lifecycle

Core PFMD projects and workstreams

Understanding, connecting and synergising towards a meta-framework

SYNaPsE – your patient engagement hub

SYNaPsE – PFMD’s Global Mapping and Networking Tool aims to SYNergise Patient Engagement. It’s a dynamic user-populated platform that categorises and ‘maps’ patient engagement initiatives and frameworks, and organisations active in patient engagement.

Find out more

Pledge to Patients

Individual pledge to Patients unites the whole patient engagement community under a common objective – a personal commitment to work with patients for patients. Whether you are an independent academic researcher, a clinical development lead in pharma, or a regulatory expert – the Pledge is for you and for anyone whose work impacts patients. Taking the Pledge to Patients means committing to simple, measurable and sustainable patient-centred principles, that will lead to better and more meaningful patient and healthcare outcomes.

Make a pledge to patients

Co-creation through Working Groups

Convened as multi-stakeholder task forces to drive co-creation of the meta-framework. Each of the 3 Working Groups is focusing on a specific phase of the medicines development lifecycle.

Find out more

Stakeholder Matrix Survey

An ongoing project to understand what stakeholders expect and require for effective and meaningful patient engagement in the medicine development lifecycle.

Find out more

Partners and Members

What’s hot in patient engagement

Video interviews